Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.

GRACEcast Treatments and Support Video

[email protected] (cancerGRACE - H. Jack West, MD)

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

JUL 22, 20142 MIN
GRACEcast Treatments and Support Video

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

JUL 22, 20142 MIN

Description

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.